"Le GROUPE IOL est le Groupe de santé oculaire des Laurentides. Il réunit sous un même toit: l'Institut de l'oeil des Laurentides; la Clinique d'ophtalmologie des Laurentides; la Clinique d'optométrie des Laurentides et le Centre de recherche en ophtalmologie des Laurentides. La mission du Groupe IOL est de contribuer au bien-être des patients en offrant des services diagnostiques et thérapeutiques accessibles, dans un environnement sécuritaire en utilisant des équipements innovateurs à la fine pointe de la technologie."

During the past decade, Institut De L'Oeil Des Laurentides conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 6 clinical trials were completed, i.e. on average, 46.2% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 6 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Institut De L'Oeil Des Laurentides" #1 sponsor was "Hoffmann-La Roche" with 10 trials, followed by "Allergan" with 1 trials sponsored, "Bayer" with 1 trials sponsored, "Clearside Biomedical, Inc." with 1 trials sponsored and "SOLX, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institut De L'Oeil Des Laurentides" #1 collaborator was "Regeneron Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Institut De L'Oeil Des Laurentides" are "Diabetic Macular Edema" (4 trials), "Geographic Atrophy" (4 trials), "Glaucoma" (1 trials), "Glaucoma, Open Angle" (1 trials) and "Glaucoma, Open-Angle" (1 trials). Many other conditions were trialed in "Institut De L'Oeil Des Laurentides" in a lesser frequency.

Most popular intervention types in "Institut De L'Oeil Des Laurentides" are "Drug" (11 trials), "Other" (8 trials), "Procedure" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (6 trials), "Faricimab" (4 trials), "Aflibercept" (2 trials), "Lampalizumab" (2 trials) and "No intervention" (2 trials). Other intervention names were less common.

The vast majority of trials in "Institut De L'Oeil Des Laurentides" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Institut De L'Oeil Des Laurentides". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Institut De L'Oeil Des Laurentides, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Institut De L'Oeil Des Laurentides, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".